These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 29294067)

  • 21. Mucormycosis: what emergency physicians need to know?
    Long B; Koyfman A
    Am J Emerg Med; 2015 Dec; 33(12):1823-5. PubMed ID: 26452511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
    Bala K; Chander J; Handa U; Punia RS; Attri AK
    Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases.
    Corzo-León DE; Chora-Hernández LD; Rodríguez-Zulueta AP; Walsh TJ
    Med Mycol; 2018 Jan; 56(1):29-43. PubMed ID: 28431008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges in the diagnosis and treatment of mucormycosis.
    Skiada A; Lass-Floerl C; Klimko N; Ibrahim A; Roilides E; Petrikkos G
    Med Mycol; 2018 Apr; 56(suppl_1):93-101. PubMed ID: 29538730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cluster of mucormycosis infections in hematology patients: challenges in investigation and control of invasive mold infections in high-risk patient populations.
    Llata E; Blossom DB; Khoury HJ; Rao CY; Wannemuehler KA; Noble-Wang J; Langston AA; Ribner BS; Lyon GM; Arnold KE; Jackson DR; Brandt ME; Chiller TM; Balajee SA; Srinivasan A; Magill SS
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):72-80. PubMed ID: 21851872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive Fungal Infections Secondary to Traumatic Injury.
    Kronen R; Liang SY; Bochicchio G; Bochicchio K; Powderly WG; Spec A
    Int J Infect Dis; 2017 Sep; 62():102-111. PubMed ID: 28705753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus.
    Trief D; Gray ST; Jakobiec FA; Durand ML; Fay A; Freitag SK; Lee NG; Lefebvre DR; Holbrook E; Bleier B; Sadow P; Rashid A; Chhabra N; Yoon MK
    Br J Ophthalmol; 2016 Feb; 100(2):184-8. PubMed ID: 26112869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.
    Feng J; Sun X
    Infection; 2018 Aug; 46(4):503-512. PubMed ID: 29748841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Our 2014 approach to mucormycosis.
    Tacke D; Koehler P; Markiefka B; Cornely OA
    Mycoses; 2014 Sep; 57(9):519-24. PubMed ID: 24829170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why is mucormycosis more difficult to cure than more common mycoses?
    Katragkou A; Walsh TJ; Roilides E
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():74-81. PubMed ID: 24279587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary mucormycosis.
    Hamilos G; Samonis G; Kontoyiannis DP
    Semin Respir Crit Care Med; 2011 Dec; 32(6):693-702. PubMed ID: 22167397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucormycosis: New Developments into a Persistently Devastating Infection.
    Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F
    Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal mucormycosis: a rare entity in pediatric oncology.
    Radhakrishnan N; Yadav SP; Oberoi J; Kulshreshta R; Bhalla S; Sachdeva A
    Pediatr Hematol Oncol; 2013 Apr; 30(3):178-83. PubMed ID: 23410194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016.
    Heimann SM; Vehreschild MJGT; Cornely OA; Heinz WJ; Grüner B; Silling G; Kessel J; Seidel D; Vehreschild JJ
    J Hosp Infect; 2019 Mar; 101(3):339-346. PubMed ID: 30423409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing acute invasive fungal sinusitis.
    Dwyhalo KM; Donald C; Mendez A; Hoxworth J
    JAAPA; 2016 Jan; 29(1):48-53. PubMed ID: 26704655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mucormycosis: therapeutic news].
    Pilmis B; Lanternier F; Lortholary O
    Med Sci (Paris); 2013 Mar; 29 Spec No 1():25-30. PubMed ID: 23510522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
    Lortholary O; Fernández-Ruiz M; Perfect JR
    J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
    Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
    Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outbreak of cutaneous zygomycosis associated with the use of adhesive tape in haematology patients.
    Lalayanni C; Baliakas P; Xochelli A; Apostolou C; Arabatzis M; Velegraki A; Anagnostopoulos A
    J Hosp Infect; 2012 Jul; 81(3):213-5. PubMed ID: 22633275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucormycosis: An 8-year experience of a tertiary care centre in Saudi Arabia.
    Elzein F; Albarrag A; Kalam K; Arafah M; Al-Baadani A; Eltayeb N; Aloteibi F; Alrashed A; Abdullah RA; Alasiri S
    J Infect Public Health; 2020 Nov; 13(11):1774-1779. PubMed ID: 32891591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.